Secondary immunodeficiencies result from acquired conditions that compromise immune function: infections (HIV destroying CD4+ T cells), malnutrition (reduced T cell and antibody production), malignancy (immune suppression and lymphoid infiltration), medications (corticosteroids, biologic immunosuppressants), or blood loss. Unlike PIDs, secondary immunodeficiency may be reversible if the underlying cause is treated.
Study HIV pathogenesis and progressive CD4 decline. Compare immune defects across different causes.
Immunosuppressive drugs do not uniformly suppress all immune functions; they often selectively inhibit T cells while leaving innate immunity or antibody production intact. Secondary immunodeficiency from malnutrition is reversible with nutritional support.
You already know that immunodeficiency means some component of the immune system is missing or malfunctioning, and you have seen how primary immunodeficiencies arise from inherited genetic defects. Secondary immunodeficiencies are fundamentally different in origin: they are *acquired* conditions where a previously functional immune system becomes compromised by an external insult — an infection, a drug, a nutritional deficit, or a disease process. The distinction matters clinically because secondary immunodeficiencies are often reversible if you can identify and treat the underlying cause.
The most instructive example is HIV/AIDS. HIV selectively infects CD4+ T helper cells — the coordinators of the adaptive immune response you studied earlier. As the virus replicates and destroys these cells over months to years, the CD4 count progressively drops. When it falls below roughly 200 cells per microliter (normal is 500–1500), the patient loses the ability to mount effective cell-mediated and humoral responses, and opportunistic infections emerge — organisms like *Pneumocystis jirovecii* and *Cryptococcus neoformans* that a healthy immune system would easily contain. This progression illustrates a general principle: the specific immune defect determines which infections become dangerous. Loss of T cells predisposes to intracellular pathogens and fungi; loss of antibodies predisposes to encapsulated bacteria; loss of neutrophils predisposes to bacterial and fungal skin and mucosal infections.
Malnutrition is the most common cause of secondary immunodeficiency worldwide, yet it is often overlooked in clinical teaching. Protein-calorie malnutrition impairs thymic function, reduces circulating T cell numbers, and decreases antibody production — essentially mimicking a combined immunodeficiency. Specific micronutrient deficiencies (zinc, vitamin A, iron) each compromise distinct immune pathways. The critical insight is that nutritional immunodeficiency is fully reversible with adequate nutritional support, which separates it sharply from genetic immunodeficiencies.
Iatrogenic immunosuppression — immune dysfunction caused by medical treatment — is increasingly common. Corticosteroids broadly suppress inflammation by blocking NF-κB signaling and reducing cytokine production, but they do not shut down all arms of immunity equally. Biologic immunosuppressants like anti-TNF antibodies or anti-CD20 (rituximab) target specific molecules, creating selective immune gaps: rituximab depletes B cells and impairs antibody production while leaving T cell function largely intact, whereas calcineurin inhibitors (cyclosporine, tacrolimus) primarily block T cell activation. Understanding which arm of immunity a drug suppresses lets you predict which infections the patient is now vulnerable to — the same logic you applied to primary immunodeficiencies, but now with the added clinical lever that adjusting or withdrawing the drug can restore immune function.
No topics depend on this one yet.